Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Cancer Treatment Reviews
|
September 15, 2020
Organoid models in gynaecological oncology research
Anita Semertzidou, Jan J Brosens, Iain McNeish, et al.
BMJ Open Quality
|
February 25, 2025
Key clinical findings from the IMPROVE-UK quality improvement projects: an overview
Andrew James Phillips, Rebecca Bowen, Mary Wells, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 23, 2025
Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube
Olivia Le Saux, Iain McNeish, Maurizio D'Incalci, et al.
Molecular Cancer
|
March 10, 2010
CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus
Taha Elmetwali, Peter F Searle, Iain McNeish, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 27, 2025
What is the evidence for dietary modification in the management and prevention of malignant bowel obstruction? A scoping review
Ellie Ware, Laura Tookman, Erin Stella Sullivan, et al.
Cancer Research
|
January 21, 2006
Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin
Michelle Lockley, Mario Fernandez, Yaohe Wang, et al.
Oncotarget
|
February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer
Helen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
The Journal of Reproductive Medicine
|
July 3, 2002
Management of brain metastases in patients with high-risk gestational trophoblastic tumors
Edward S Newlands, Lydia Holden, Michael J Seckl, et al.
Scientific Reports
|
February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management
Megan Rumford, Mark Lythgoe, Iain McNeish, et al.
International Journal of Cancer
|
January 28, 2010
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Barbara Delage, Dean A Fennell, Linda Nicholson, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Cancer Treatment Reviews
|
September 15, 2020
Organoid models in gynaecological oncology research
Anita Semertzidou, Jan J Brosens, Iain McNeish, et al.
BMJ Open Quality
|
February 25, 2025
Key clinical findings from the IMPROVE-UK quality improvement projects: an overview
Andrew James Phillips, Rebecca Bowen, Mary Wells, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 23, 2025
Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube
Olivia Le Saux, Iain McNeish, Maurizio D'Incalci, et al.
Molecular Cancer
|
March 10, 2010
CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus
Taha Elmetwali, Peter F Searle, Iain McNeish, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 27, 2025
What is the evidence for dietary modification in the management and prevention of malignant bowel obstruction? A scoping review
Ellie Ware, Laura Tookman, Erin Stella Sullivan, et al.
Cancer Research
|
January 21, 2006
Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin
Michelle Lockley, Mario Fernandez, Yaohe Wang, et al.
Oncotarget
|
February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer
Helen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
The Journal of Reproductive Medicine
|
July 3, 2002
Management of brain metastases in patients with high-risk gestational trophoblastic tumors
Edward S Newlands, Lydia Holden, Michael J Seckl, et al.
Scientific Reports
|
February 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management
Megan Rumford, Mark Lythgoe, Iain McNeish, et al.
International Journal of Cancer
|
January 28, 2010
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Barbara Delage, Dean A Fennell, Linda Nicholson, et al.
Page
of 7